BMJ open · 2016
Possible role of IL-6 and TIE2 gene polymorphisms in predicting the initial high transport status in patients with peritoneal dialysis: an observational study.
СтатьяПоддержка исследования: вне правительства СШАНаблюдательное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ding Li, Shao Xinghua, Cao Liou, Fang Wei, Yan Hao, Huang Jiaying, Gu Aiping, Yu Zanzhe, Qi Chaojun, Chang Xinbei, Ni Zhaohui
Аннотация
OBJECTIVES: The aim of this study was to investigate the effect of interleukin (IL)-6 and TIE2 gene polymorphisms on baseline peritoneal transport property.
DESIGN: An observational study.
SETTING: Renji Hospital in Shanghai, China.
PARTICIPANTS: This study included 220 patients with continuous ambulatory peritoneal dialysis (PD).
OUTCOME MEASURES: Patients were divided into 2 groups based on the results of an initial peritoneal equilibration test performed within 3 months of starting PD therapy: group 1 consisted of low/low average transporters (n=123), and group 2 consisted of high/high average transporters (n=97). We genotyped TIE2 and IL-6 polymorphisms and analysed their effects on baseline transport status.
RESULTS: The genotype AT in IL-6 Rs13306435 and the genotype CC in TIE2 Rs639225 were both negatively associated with a higher initial peritoneal transport status (IL-6 Rs13306435: OR=0.408, 95% CI 0.227 to 0.736; TIE2 Rs639225: OR=0.188, 95% CI 0.044 to 0.806).
CONCLUSIONS: IL-6 and TIE2 polymorphisms are associated with baseline peritoneal transport property.
DESIGN: An observational study.
SETTING: Renji Hospital in Shanghai, China.
PARTICIPANTS: This study included 220 patients with continuous ambulatory peritoneal dialysis (PD).
OUTCOME MEASURES: Patients were divided into 2 groups based on the results of an initial peritoneal equilibration test performed within 3 months of starting PD therapy: group 1 consisted of low/low average transporters (n=123), and group 2 consisted of high/high average transporters (n=97). We genotyped TIE2 and IL-6 polymorphisms and analysed their effects on baseline transport status.
RESULTS: The genotype AT in IL-6 Rs13306435 and the genotype CC in TIE2 Rs639225 were both negatively associated with a higher initial peritoneal transport status (IL-6 Rs13306435: OR=0.408, 95% CI 0.227 to 0.736; TIE2 Rs639225: OR=0.188, 95% CI 0.044 to 0.806).
CONCLUSIONS: IL-6 and TIE2 polymorphisms are associated with baseline peritoneal transport property.